end,filed,form,Name,Ticker,CIK,Currency,AccountsPayableAndAccruedLiabilitiesCurrent,AccountsPayableAndOtherAccruedLiabilities,AccountsPayableCurrent,AccountsPayableCurrentAndNoncurrent,AccumulatedOtherComprehensiveIncomeLossNetOfTax,AdditionalPaidInCapital,AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount,Assets,AssetsCurrent,CashAndCashEquivalentsAtCarryingValue,CashAndCashEquivalentsPeriodIncreaseDecrease,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect,CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect,CashEquivalentsAtCarryingValue,ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1,CommonStockParOrStatedValuePerShare,CommonStockSharesAuthorized,CommonStockSharesIssued,CommonStockSharesOutstanding,CommonStockValue,CostOfGoodsAndServicesSoldAmortization,DebtInstrumentAnnualPrincipalPayment,DebtInstrumentFaceAmount,DebtInstrumentInterestRateDuringPeriod,DebtSecuritiesUnrealizedGainLoss,DeferredOfferingCosts,DeferredTaxAssetsGross,DeferredTaxAssetsNet,DeferredTaxAssetsOperatingLossCarryforwards,DeferredTaxAssetsOperatingLossCarryforwardsDomestic,DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal,DeferredTaxAssetsTaxCreditCarryforwardsForeign,DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness,DeferredTaxAssetsValuationAllowance,DeferredTaxLiabilitiesGoodwillAndIntangibleAssets,DepositsAssetsNoncurrent,DepreciationDepletionAndAmortization,DerivativeCostOfHedge,EarningsPerShareBasicAndDiluted,EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate,EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance,EffectiveIncomeTaxRateReconciliationDeductions,FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet,GeneralAndAdministrativeExpense,HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue,HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue,HeldToMaturitySecuritiesFairValue,IncreaseDecreaseInAccountsPayable,IncreaseDecreaseInAccountsPayableAndAccruedLiabilities,IncreaseDecreaseInDeferredCharges,IncreaseDecreaseInPrepaidExpense,InsuranceCommissionsAndFees,InterestIncomeOther,InterestReceivable,InvestmentOwnedPercentOfNetAssets,LeaseAndRentalExpense,Liabilities,LiabilitiesAndStockholdersEquity,LiabilitiesCurrent,LongTermLoansPayable,MarketableSecuritiesCurrent,MarketableSecuritiesNoncurrent,NetCashProvidedByUsedInFinancingActivities,NetCashProvidedByUsedInInvestingActivities,NetCashProvidedByUsedInOperatingActivities,NetIncomeLoss,NetIncomeLossAttributableToNoncontrollingInterest,NetIncomeLossAvailableToCommonStockholdersBasic,OperatingExpenses,OperatingIncomeLoss,OperatingLeaseLiability,OperatingLeaseLiabilityCurrent,OperatingLeaseLiabilityNoncurrent,OperatingLeaseRightOfUseAsset,OperatingLeasesFutureMinimumPaymentsDueInThreeYears,OperatingLeasesFutureMinimumPaymentsDueInTwoYears,OperatingLeasesFutureMinimumPaymentsReceivable,OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear,OperatingLeaseWeightedAverageDiscountRatePercent,OtherAccountsPayableAndAccruedLiabilities,OtherAssetsCurrent,OtherAssetsNoncurrent,OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax,OtherGeneralAndAdministrativeExpense,OtherNonoperatingIncomeExpense,OtherPrepaidExpenseCurrent,OtherResearchAndDevelopmentExpense,PaymentsForOtherOperatingActivities,PaymentsOfStockIssuanceCosts,PaymentsToAcquireMarketableSecurities,PreferredStockParOrStatedValuePerShare,PreferredStockSharesAuthorized,PreferredStockSharesIssued,PreferredStockSharesOutstanding,PreferredStockValue,PrepaidExpenseAndOtherAssetsCurrent,PrepaidExpenseAndOtherAssetsNoncurrent,PrepaidExpenseCurrent,PrepaidExpenseCurrentAndNoncurrent,ProceedsFromIssuanceInitialPublicOffering,ProceedsFromIssuanceOfPreferredStockAndPreferenceStock,ProceedsFromLoanOriginations1,ProceedsFromLoans,ProceedsFromNotesPayable,ProceedsFromStockPlans,ProceedsFromWarrantExercises,ProfitLoss,PropertyPlantAndEquipmentNet,RepaymentsOfNotesPayable,RepaymentsOfRelatedPartyDebt,ResearchAndDevelopmentExpense,ResearchAndDevelopmentInProcess,RestrictedCash,RestrictedCashAndCashEquivalents,RestrictedCashAndCashEquivalentsAtCarryingValue,RestrictedCashEquivalents,RestrictedCashNoncurrent,RetainedEarningsAccumulatedDeficit,SaleOfStockPricePerShare,SecuritiesLoanedFairValueOfCollateral,ShareBasedCompensation,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice,ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice,SharePrice,SharesIssuedPricePerShare,ShortTermLeasePayments,StockholdersEquity,StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest,StockIssuedDuringPeriodValueAcquisitions,StockIssuedDuringPeriodValueNewIssues,StockIssuedDuringPeriodValueOther,StockIssuedDuringPeriodValueShareBasedCompensation,StockIssuedDuringPeriodValueShareBasedCompensationGross,StockIssuedDuringPeriodValueStockOptionsExercised,StockOptionDownRoundFeatureIncreaseDecreaseInEquityAmount,WeightedAverageNumberOfShareOutstandingBasicAndDiluted,AdditionalPaidInCapitalCommonStock,ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights,CommonStockCapitalSharesReservedForFutureIssuance,CommonStockDividendsShares,DeferredTaxAssetsInProcessResearchAndDevelopment,DeferredTaxAssetsTaxCreditCarryforwardsResearch,DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost,DeferredTaxAssetsUnrealizedLossesOnTradingSecurities,DeferredTaxLiabilitiesPropertyPlantAndEquipment,EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate,ExcessStockSharesAuthorized,ExcessStockSharesIssued,ExcessStockSharesOutstanding,IncreaseDecreaseInOperatingLeaseLiability,IncreaseDecreaseInOtherOperatingAssets,OperatingCostsAndExpenses,OtherExpenses,OwnshareLendingArrangementSharesIssued,PartnersCapitalAccountUnitsSoldInPublicOffering,ProceedsFromSaleAndMaturityOfMarketableSecurities,PublicUtilitiesApprovedRateIncreaseDecreaseAmount,PurchaseObligation,ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod,ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee,ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1,SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares,StockIssuedDuringPeriodSharesPurchaseOfAssets,StockIssuedDuringPeriodSharesStockOptionsExercised,StockOptionExercisePriceIncrease,StockRepurchasedDuringPeriodValue,StockRepurchaseProgramAuthorizedAmount1,StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased
2020-06-30,2020-07-30,10-Q,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,,467988.0,102831.0,,,31289650.0,,25613034.0,25597657.0,23798343.0,,,,,,,0.0001,25000000.0,6217577.0,6217577.0,622.0,,,,,,,,,,,,,,,,,,,-0.31,,,,,676399.0,,,,,,,,,,,0.8,,2385165.0,25613034.0,2276665.0,108500.0,,,,,,-833422.0,,,833422.0,-833422.0,,,,,,,,,,,1728539.0,,,12000.0,,,,,,,0.0001,1000000.0,0.0,0.0,,,,70775.0,70775.0,,,,,,,,-833422.0,15377.0,,,157023.0,157023.0,,,,,,-8062403.0,,,105000.0,,,,508966.0,,,,,,,,,,,,,,23227869.0,23227869.0,,,,,105363.0,23419721.0,,2719198.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2020-09-30,2020-10-29,10-Q,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,,814557.0,,108500.0,,31333164.0,,22492952.0,22475344.0,20802542.0,,20802542.0,,,,18.75,0.0001,25000000.0,6217577.0,6217577.0,622.0,,,103000.0,,,0.0,,,,,,,,,,,,,-0.27,,,,,1100719.0,,,,,,,,,,,0.8,,923057.0,22492952.0,814557.0,,,,,,,-1701488.0,,-1701488.0,1701488.0,-1701488.0,,,,,,,,,,,65000.0,,,1000.0,,,,,,,0.0001,1000000.0,0.0,0.0,,1672802.0,1673000.0,,6000.0,,,,,,,,-1701488.0,17608.0,,,600769.0,600769.0,,20802542.0,20802542.0,,,-9763891.0,,,43000.0,,,,515695.0,,,,,,,,,,,1.03,1.03,,21569895.0,,,,,43000.0,43514.0,,,6217577.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2020-12-31,2021-03-10,10-K,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,552339.0,552339.0,,108500.0,,32358068.0,1161226.0,20359634.0,20236922.0,19229232.0,17997202.0,19229232.0,,,0.0,6.49,0.0001,25000000.0,6220927.0,6220927.0,622.0,,,103000.0,,,101205.0,2855999.0,6237.0,2417169.0,11500000000000.0,71000.0,181000.0,3100000.0,2849762.0,6237.0,101205.0,3388.0,,-1.37,0.21,-0.22,0.01,,3664965.0,,,,-169049.0,117167.0,49325.0,1006902.0,,,,0.8,,660839.0,20359634.0,552339.0,,,,23664960.0,-16137.0,-5651621.0,-5908190.0,5908000.0,-5908190.0,5908190.0,,,,,,,,,,,,,,,27000.0,,1008000.0,,,,,0.0001,1000000.0,0.0,0.0,,1007690.0,1008000.0,,85000.0,,26250000.0,,,169049.0,52000.0,,-5908190.0,21507.0,,,2243225.0,2243225.0,0.0,19229232.0,19229232.0,,,-12659895.0,,,,0.0,0.8325,0.0055,,43166.0,,321743.0,11.02,10727000.0,835608.0,6.41,1.03,1.03,15.01,,1.03,,19698795.0,,,23419721.0,,,1192241.0,52000.0,1192241.0,4304918.0,36000.0,325618.0,,,180889.0,,257941.0,,6237.0,0.01,25000000.0,6220927.0,6220927.0,,,5908190.0,519000.0,,,,,,835608.0,,21000.0,9774000.0,,,50460.0,,,,
2021-03-31,2021-05-03,10-Q,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,,664533.0,,108500.0,,96842698.0,,82504659.0,82484495.0,81373725.0,,,,62144493.0,,,0.0001,25000000.0,11181447.0,11181447.0,1118.0,,,,,,0.0,,,,,,,,,,,1343.0,658000.0,-0.24,,,,,1173258.0,,,,,164074.0,,103080.0,,,,,,773033.0,82504659.0,664533.0,,,,64288932.0,,-2144439.0,-2452295.0,,-2316481.0,2452295.0,,,,,,,,,,,240000.0,,,,,,607000.0,24215.0,1033000.0,,,0.0001,1000000.0,,,,1110770.0,1111000.0,,,,,,,,,72754.0,-2452295.0,20164.0,,,1279037.0,,,,,,,-15112190.0,3.13,,,,,,,,,,,,823826.0,6.49,1.03,,,,,,81731626.0,,,64166854.0,64166854.0,105000.0,245519.0,72753.0,245519.0,10074623.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-06-30,2021-07-29,10-Q,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,1093787.0,,,,-47565.0,97088382.0,,82432073.0,82131083.0,61354117.0,,,,,1670000.0,,0.0001,25000000.0,11184039.0,11184039.0,1118.0,,,,,,,,,,,,,,,,,,,-0.21,,,,,1314201.0,6813417.0,612762.0,12205840.0,,,,,,47889.0,76000.0,,,2818809.0,82432073.0,2688104.0,,18234540.0,18234540.0,,,,-2316481.0,,,2479093.0,-2479093.0,276603.0,145898.0,130705.0,252503.0,53403.0,158403.0,289202.0,77396.0,0.0465,,,17889.0,-47565.0,27000.0,114723.0,2542000.0,,,,,0.0001,1000000.0,,,,2542426.0,,,,,,,,,,,-2316481.0,30598.0,,,1164892.0,,,,,,,-17428671.0,,14198440.0,,,,,,,,,,,823826.0,6.49,,,,1.03,3.13,,79613264.0,,,,,,245684.0,,,11181504.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-09-30,2021-11-01,10-Q,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,1636639.0,,,,-102689.0,97312794.0,,77606197.0,76336642.0,54669020.0,,55669020.0,,,768000.0,,0.0001,25000000.0,11186999.0,11186999.0,1119.0,,,,,,,,,,,,,,,,,,,-0.36,,,,,1184486.0,6059006.0,2185149.0,13152583.0,,,,,,77219.0,71000.0,,,1877623.0,77606197.0,1785599.0,,19163533.0,13152583.0,,,,-4053979.0,,-4053979.0,4148877.0,-4148877.0,240984.0,148960.0,92024.0,219431.0,53403.0,158403.0,250504.0,38698.0,0.0465,,,17889.0,-55124.0,38000.0,17679.0,2504000.0,,,,,0.0001,1000000.0,0.0,0.0,,2504089.0,,,,,,,,,,,-4053979.0,32235.0,,,2964391.0,,1000000.0,55669020.0,54669020.0,1000000.0,1000000.0,-21482650.0,,,,,,,,,,,,,801588.0,6.25,,,,,3.13,,75728574.0,,,,,,224413.0,,,11186259.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
2021-12-31,2022-03-10,10-K,Lantern Pharma Inc.,LTRN,CIK0001763950,USD,2174109.0,,,,-92689.0,96685924.0,,73950477.0,72716400.0,51524295.0,33295063.0,52524295.0,,,631000.0,,0.0001,25000000.0,11088835.0,11088835.0,1109.0,,,,,-92872.0,,5772113.0,5054.0,4837807.0,22800000000000.0,468000.0,,,5767059.0,,,6761.0,,-1.13,0.21,-0.24,,19201152.0,5020928.0,5072635.0,3083858.0,13255852.0,,1622084.0,,984463.0,,67929.0,181000.0,,2000.0,2379057.0,73950477.0,2326167.0,,19201152.0,,63416122.0,-19530586.0,-10591543.0,-12363029.0,12363000.0,-12363029.0,12591508.0,,204948.0,152058.0,52890.0,185943.0,53403.0,158403.0,211806.0,,0.0465,,,17889.0,-92689.0,105000.0,160550.0,1991000.0,,,261.0,19579180.0,0.0001,1000000.0,0.0,0.0,,1990953.0,,,,,68999994.0,,,,139610.0,,-12363029.0,30245.0,,,7570580.0,,1000000.0,52524295.0,51524295.0,1000000.0,1000000.0,-25022924.0,,,,0.0,0.907,0.013,,43500.0,,110500.0,7.55,3490000.0,890826.0,6.54,1.03,15.0,10.28,,,,71571420.0,,,64166854.0,,,961545.0,12135.0,961545.0,10904927.0,,273777.0,1489680.0,40727.0,479849.0,480000.0,427524.0,26933.0,5054.0,0.03,25000000.0,11088835.0,11088835.0,-71655.0,-33991.0,12591508.0,4483000.0,8318.0,,64093.0,1.25,,890826.0,468099.0,213000.0,3490000.0,2110000.0,11114.0,11782.0,3.13,939666.0,,
